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Noncompaction with dysmorphism, 
mental retardation, general wasting, 
and hypogonadism requires 
neurologic and sophisticated 
cytogenetic investigations
To the Editor,
We read with interest the article published entitled “Case of fatal 
heart failure with biventricular noncompaction, genital skeletal abnor-
malities and mental retardation.” by Ataş et al. (1) regarding a 48-year-
old female from consanguineous parents with dilated cardiomyopathy 
(dCMP), left ventricular hypertrabeculation/noncompaction (LVHT), 
primary amenorrhea, bilateral amazia, ovarian dysgenesis, uterine 
aplasia, hypergonadotropic hypogonadism, macrocephaly, facial acro-
megaly, arachnodactyly, pectus carinatum, and mental retardation who 
died from heart failure 4 months after being diagnosed with LVHT. We 
have the following comments and concerns.
We do not agree with the statement that LVHT is a genetic disorder. 
Although LVHT is associated with various monogenic disorders, in par-
ticular neuromuscular disorders (NMDs) and cardiomyopathies, and 
chromosomal defects (2), a causal relation between these genetic 
defects and LVHT has not yet been proven. The strongest argument 
against a causal relation is that only a small number of patients with 
NMDs, cardiomyopathies, and chromosomal defects present with LVHT 
(2). An argument in favor of a causal relation, however, is that LVHT also 
occurs familial (3).
The patient underwent cytogenetic investigation; however, it is not 
mentioned which technique was applied (1). Did the authors investigate 
complex chromosomal re-arrangements and micro-aberrations by means 
of fluorescence in-situ-hybridization (FISH) or microarray assays? In 
particular, did they apply multi-color FISH, telomere/subtelomer FISH, 
reverse painting, fiber FISH, quantitative FISH, or cobra-FISH?
According to Figure 1, the patient presented with generalized mus-
cle wasting (1). Was this due to being bedridden prior to admission or 
was this due to involvement of the peripheral nerves or the skeletal 
muscles? Did the patient ever undergo a clinical neurologic investiga-
tion, nerve conduction studies, or needle electromyography? This is of 
particular importance because LVHT is associated with NMDs in more 
than half of the cases.
Concerning mental retardation and macrocephaly, it would be 
interesting to know cerebral imaging results. Was there cerebral atro-
phy, calcification, demyelination, or hydrocephalus? Did she ever 
develop seizures? Was an electroencephalogram ever recorded?
Because LVHT can be complicated by stroke embolism, it is impor-
tant to understand whether the individual or family history was positive 
for stroke/embolism. Did cerebral imaging reveal previous embolic 
stroke? Furthermore, patients with LVHT and dCMP require oral antico-
agulation with vitamin-K antagonists for primary prophylaxis of stroke/
embolism (4). Did the patient receive phenprocoumon or warfarin in 
addition to heart failure therapy on dismissal? 
Furthermore, because LVHT is complicated by arrhythmias, it would 
be worthwhile to know the results of long-term electrocardiography 
recordings. Did the two sisters and brother who deceased in childhood 
die suddenly? Was the family history positive for falls, syncope, fainting, 
or sudden cardiac death? Was an autopsy conducted in the three 
deceased children?
Because LVHT may be acquired in some cases (5), it would be 
interesting to know whether the patient had undergone previous echo-
cardiographies and if these were revised for LVHT?
Overall, this interesting case merits further evaluation with regard 
to genetic background and possible neuromuscular or cerebral comor-
bidities. Only if LVHT patients are comprehensively investigated, the 
pathogenetic background of this enigmatic cardiac abnormality may be 
elucidated.
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